tiprankstipranks
Trending News
More News >
Crinetics Pharmaceuticals: A Promising Investment with Multiple Growth Opportunities
PremiumRatingsCrinetics Pharmaceuticals: A Promising Investment with Multiple Growth Opportunities
19d ago
Crinetics Pharmaceuticals: Promising Pipeline and Strategic Positioning Justify Buy Rating
Premium
Ratings
Crinetics Pharmaceuticals: Promising Pipeline and Strategic Positioning Justify Buy Rating
29d ago
Crinetics treatment of carcinoid syndrome granted FDA orphan status
Premium
The Fly
Crinetics treatment of carcinoid syndrome granted FDA orphan status
1M ago
Crinetics Pharmaceuticals Reports Q1 2025 Financial Results
PremiumCompany AnnouncementsCrinetics Pharmaceuticals Reports Q1 2025 Financial Results
2M ago
Crinetics Pharmaceuticals: Promising Outlook with Paltusotine Approval and Strategic Market Positioning
Premium
Ratings
Crinetics Pharmaceuticals: Promising Outlook with Paltusotine Approval and Strategic Market Positioning
2M ago
Crinetics reports Q1 EPS ($1.04), consensus (95c)
Premium
The Fly
Crinetics reports Q1 EPS ($1.04), consensus (95c)
2M ago
Crinetics Pharmaceuticals: Promising Transition to Commercialization Amidst Safety Concerns and Strategic Market Positioning
PremiumRatingsCrinetics Pharmaceuticals: Promising Transition to Commercialization Amidst Safety Concerns and Strategic Market Positioning
4M ago
Crinetics Pharmaceuticals: Promising Developments and Strategic Initiatives Underpin Buy Rating
Premium
Ratings
Crinetics Pharmaceuticals: Promising Developments and Strategic Initiatives Underpin Buy Rating
4M ago
Crinetics price target lowered to $91 from $92 at Citizens JMP
Premium
The Fly
Crinetics price target lowered to $91 from $92 at Citizens JMP
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100